Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Women with PCOS have lower quality of life, especially in mental health and energy, and managing weight can help improve it.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Relatives of women with PCOS symptoms are more likely to have similar health issues.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Finasteride safely reduces excessive hair growth in women.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Irisin and GIP levels are not linked to BMI in women, regardless of PCOS status.